Showing results (381-390 of 587) with videos related to
Sort By:
Pageof 59
Applied Health Economics and Health Policy|October 22, 2016
Ethical Hurdles in the Prioritization of Oncology CareFolkert de Groot, Stefano Capri, Jean-Claude Castanier, et al.Annals of Surgical Oncology|October 18, 2022
The Cancer Hub Approach for Upper Gastrointestinal Surgery During COVID-19 Pandemic: Outcomes from a UK Cancer CentreJoseph P Doyle, Pranav H Patel, Sophie L F Doran, et al.Molecular Cancer Therapeutics|July 3, 2019
Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in KRAS-Mutant CancersAdam Stewart, Elizabeth A Coker, Sebastian Pölsterl, et al.Oncotarget|February 11, 2016
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trialKhurum Khan, David Cunningham, Clare Peckitt, et al.Heart (British Cardiac Society)|July 24, 2014
Device-dependent association between paravalvar aortic regurgitation and outcome after TAVIRafal Dworakowski, Olaf Wendler, Brian Halliday, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusEric Van Cutsem, Claus-Henning Köhne, István Láng, et al.Cell Reports|September 8, 2015
Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXRLinara Gabitova, Diana Restifo, Andrey Gorin, et al.Journal of Lipid Research|December 8, 2009
Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infectionRonald W Clark, David Cunningham, Yang Cong, et al.BJC Reports|November 8, 2024
Incidental finding of leukaemia in circulating tumour DNA- the importance of a molecular tumour boardJustin Mencel, Neha Rayarel, Paula Proszek, et al.International Journal of Cancer|June 15, 2019
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patientsFrancesco Sclafani, Sanna Hulkki Wilson, David Cunningham, et al.Pageof 59